455 related articles for article (PubMed ID: 23955585)
61. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
Ke S; Zhan S; Zhu H; Yan D
J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
[TBL] [Abstract][Full Text] [Related]
62. Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Ychou M; Rivoire M; Thezenas S; Guimbaud R; Ghiringhelli F; Mercier-Blas A; Mineur L; Francois E; Khemissa F; Chauvenet M; Kianmanesh R; Fonck M; Houyau P; Aparicio T; Galais MP; Audemar F; Assenat E; Lopez-Crapez E; Jouffroy C; Adenis A; Adam R; Bouché O
Br J Cancer; 2022 May; 126(9):1264-1270. PubMed ID: 34992255
[TBL] [Abstract][Full Text] [Related]
63. [Prognostic analysis of patients with liver metastases from colorectal cancer treated with different modes of therapy].
Fang H; Wang XY; Feng FY; Wang JW
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):67-70. PubMed ID: 20211074
[TBL] [Abstract][Full Text] [Related]
64. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.
Lam VW; Spiro C; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
Ann Surg Oncol; 2012 Apr; 19(4):1292-301. PubMed ID: 21922338
[TBL] [Abstract][Full Text] [Related]
65. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
66. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.
Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872
[TBL] [Abstract][Full Text] [Related]
67. Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.
Semrad TJ; Fahrni AR; Gong IY; Khatri VP
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S855-62. PubMed ID: 26100816
[TBL] [Abstract][Full Text] [Related]
68. Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
Krishnamurthy A; Kankesan J; Wei X; Nanji S; Biagi JJ; Booth CM
Eur J Surg Oncol; 2017 Feb; 43(2):364-371. PubMed ID: 27727025
[TBL] [Abstract][Full Text] [Related]
69. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
70. Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Holch JW; Ricard I; Stintzing S; Fischer von Weikersthal L; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Kullmann F; Scheithauer W; Scholz M; Müller S; Link H; Rost A; Höffkes HG; Moehler M; Lindig RU; Miller-Phillips L; Kirchner T; Jung A; von Einem JC; Modest DP; Heinemann V
Int J Cancer; 2018 Mar; 142(5):1047-1055. PubMed ID: 29047142
[TBL] [Abstract][Full Text] [Related]
71. [Predictors and outcomes of recurrence after resection of colorectal liver metastases].
Sun Y; Yan X; Wang K; Bao Q; Wang H; Jin K; Xing B
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1232-6. PubMed ID: 24924887
[TBL] [Abstract][Full Text] [Related]
72. Multidisciplinary approach of colorectal liver metastases.
Juez I; Rubio C; Figueras J
Clin Transl Oncol; 2011 Oct; 13(10):721-7. PubMed ID: 21975333
[TBL] [Abstract][Full Text] [Related]
73. Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).
Sorbye H; Mauer M; Gruenberger T; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Collette L; Van Cutsem E; Scheithauer W; Lutz MP; Nordlinger B; ; ; ; ;
Ann Surg; 2012 Mar; 255(3):534-9. PubMed ID: 22314329
[TBL] [Abstract][Full Text] [Related]
74. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.
Folprecht G; Grothey A; Alberts S; Raab HR; Köhne CH
Ann Oncol; 2005 Aug; 16(8):1311-9. PubMed ID: 15870084
[TBL] [Abstract][Full Text] [Related]
75. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Collette L; Praet M; Bethe U; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
Lancet; 2008 Mar; 371(9617):1007-16. PubMed ID: 18358928
[TBL] [Abstract][Full Text] [Related]
76. Impact of timing and cycles of systemic chemotherapy on survival outcome of colorectal liver metastases patients treated by percutaneous microwave ablation.
Zhang K; Yu J; Zhou F; Yu X; Li X; Wang J; Han Z; Cheng Z; Liang P
Int J Hyperthermia; 2016 Aug; 32(5):531-8. PubMed ID: 27121037
[TBL] [Abstract][Full Text] [Related]
77. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?
Dueland S; Guren TK; Hagness M; Glimelius B; Line PD; Pfeiffer P; Foss A; Tveit KM
Ann Surg; 2015 May; 261(5):956-60. PubMed ID: 24950280
[TBL] [Abstract][Full Text] [Related]
78. Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
Khushman M; Dempsey N; Maldonado JC; Loaiza-Bonilla A; Velez M; Carcas L; Dammrich D; Hurtado-Cordovi J; Parajuli R; Pollack T; Harwood AP; Macintyre J; Tzeng CW; Merchan JR; Restrepo MH; Akunyili II; Ribeiro A; Narayanan G; Portelance L; Sleeman D; Levi JU; Lima CM; Hosein PJ
Pancreatology; 2015; 15(6):667-73. PubMed ID: 26412296
[TBL] [Abstract][Full Text] [Related]
79. [Clinical Application of Microwave Ablation in Potentially Resectable Colorectal Cancer With Simultaneously Multiple Liver Metastases].
Han L; Wu XL; Guo F; Xi YN; Chang XY; Zhang CZ; Zhang JF; Ma PC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):161-168. PubMed ID: 38686711
[TBL] [Abstract][Full Text] [Related]
80. [Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].
Mizota S; Ikeda S; Yamauchi M; Imaoka Y; Mashima H; Okimoto S; Takakura Y; Noma M; Ohara M; Oishi K; Kohashi T; Fudaba Y; Ishimoto T; Matsugu Y; Nakahara H; Urushihara T; Shinozaki K; Itamoto T
Gan To Kagaku Ryoho; 2014 May; 41(5):595-600. PubMed ID: 24917004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
